NCT00586287View on ClinicalTrials.gov

Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon

PHASE4CompletedINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Pulmonary EmbolismAtrial FibrillationHip Replacement PostoperativeKnee Replacement Postoperative
Interventions
OTHER

Algorithm for phenprocoumon

Dosing of phenprocoumon for days 1 to 3, measuring INR and adjust dose according algorithm A published in (Good AC, Henz S. A clinical algorithm to predict the loading dose of phenprocoumon. Thromb Res. 2007;120(6):921-5.)

OTHER

algorithm for phenprocoumon

Dosing of phenprocoumon for days 1 to 3, measuring INR and adjust dose according algorithm B published in (Good AC, Henz S. A clinical algorithm to predict the loading dose of phenprocoumon. Thromb Res. 2007;120(6):921-5.)

DRUG

Phenprocoumon

Dosing of phenprocoumon for days 1 to 3, measuring INR and adjust dose according to the discretion of the treating physician

Trial Locations (1)

CH-9007

Cantonal Hospital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Cantonal Hospital of St. Gallen

OTHER

NCT00586287 - Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon | Biotech Hunter | Biotech Hunter